Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f7b665fb8f15d0e2b0911539d39f8a2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4155 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate |
2005-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_415ab1a7c6db652f877fe4758c1e89e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c92da31969092a365b1fe2337e65caf1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_551cf4621b69233889d5e5e8316ef09f |
publicationDate |
2007-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2286920-A1 |
titleOfInvention |
DERIVATIVES OF ARIL (OR HETEROARIL) AZOLILCARBINOLES FOR THE TREATMENT OF FIBROMIALGIA. |
abstract |
Aril derivatives (ornheteroaryl) azolylcarbinoles for the treatment ofnfibromyalgian n n The present invention relates to thenuse of aryl derivatives (ornheteroaryl) azolylcarbinoles of general formula (I) and theirnphysiologically acceptable salts as medicinal products fornhuman and / or animal therapy for the treatment of symptomsnof fibromyalgia, prevention or prophylaxis of symptoms ofnfibromyalgia as well as disease prevention or prophylaxisnIt causes the symptoms. |
priorityDate |
2005-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |